Washington, February 9: Johnson and Johnson (JNJ) has finally got a green signal from The Food and Drug Administration (FDA), to market a device that could be a potential cure for the common heart-rhythm disorder called atrial fibrillation. This is the first ever approval given by the FDA for a device of this kind.
The Food and Drug Administration (FDA) has approved the first of its kind drug made from the Genetically Engineered (GE) livestock. The drug called ATryn has been manufactured by GTC Biotherapeutics Inc.
